KALA
Kala Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$147.00M
P/E Ratio
—
EPS
$-5.64
Beta
-1.99
52W High
$20.60
52W Low
$0.14
50-Day MA
$0.35
200-Day MA
$3.77
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Kala Pharmaceuticals Inc
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of therapies using its proprietary nanoparticle-based mucus penetrating particle (MPP) technology for the treatment of eye diseases. The company is headquartered in Watertown, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $1.33M |
| EBITDA | $-41.31M |
| Operating Margin | 0.00% |
| Return on Equity | -708.00% |
| Return on Assets | -65.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-1.17 |
| Price-to-Book | 1.98 |
| Price-to-Sales (TTM) | 23.75 |
| EV/Revenue | 0.0421 |
| EV/EBITDA | -0.16 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $911.33M |
| Float | $7.66M |
| % Insiders | 0.01% |
| % Institutions | 0.77% |
Data last updated: 4/8/2026